美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tevogen Bio Holdings Inc.

0.0568

+0.009620.34%

成交量：8.70萬

成交額：4,038.28

市值：- -

市盈率：- -

高：0.0568

開：0.0453

低：0.0440

收：0.0472

資料載入中...

總覽公司新聞公告

Tevogen Bio Holdings Inc.盤中異動急速跳水5.04%報1.31美元

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌5.17%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.43%

Tevogen Bio Holdings Inc.盤中異動大幅跳水6.58%報1.26美元

Tevogen Bio Holdings Inc.盤中異動大幅跳水5.71%報0.990美元

Tevogen Bio Holdings Inc.盤中異動早盤快速下挫5.14%報1.02美元

Tevogen Bio Holdings Inc.盤中異動下午盤股價大漲5.92%

Tevogen Bio Holdings Inc.盤中異動急速下跌5.88%報0.960美元

Tevogen Bio Holdings Inc.盤中異動大幅拉昇5.06%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.14%報1.02美元

Tevogen Bio Holdings Inc.盤中異動股價大跌5.31%報1.07美元

Tevogen Bio Holdings Inc.盤中異動早盤快速下挫5.05%

Tevogen Bio Holdings Inc.盤中異動股價大跌5.85%

Tevogen Bio Holdings Inc.盤中異動大幅下挫5.34%

Tevogen Bio Holdings Inc.盤中異動大幅下挫5.04%報1.30美元

Tevogen Bio Holdings Inc.盤中異動股價大漲7.04%

Tevogen Bio Holdings Inc.盤中異動快速下挫5.33%報1.42美元

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌7.01%

Tevogen Bio Holdings Inc.股價上漲21.76% 市值漲6149.18萬美元

Tevogen Bio Holdings Inc.盤中異動早盤股價大跌5.21%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TVGNW/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0568,"timestamp":1743624000000,"preClose":0.0472,"halted":0,"volume":86996,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":0.0096,"latestTime":"04-02 16:00:00 EDT","open":0.0453,"high":0.0568,"low":0.044,"amount":4038.276,"amplitude":0.271186,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0472,"volumeRatio":0.293859},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.293859,"shares":0,"dividePrice":0,"high":0.0568,"amplitude":0.271186,"preClose":0.0472,"low":0.044,"week52Low":0.0099,"pbRate":"--","week52High":0.1499,"institutionHeld":0,"latestPrice":0.0568,"eps":0,"divideRate":0,"volume":86996,"delay":0,"ttmEps":0,"open":0.0453,"prevYearClose":0.054,"prevWeekClose":0.0579,"prevMonthClose":0.0539,"prevQuarterClose":0.0539,"fiveDayClose":0.0578,"twentyDayClose":0.0699,"sixtyDayClose":0.0596},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGNW\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503797245","title":"Tevogen Bio Holdings Inc.盤中異動 急速跳水5.04%報1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503797245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503797245?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 22:37","pubTimestamp":1736865454,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时37分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.31美元/股，成交量9.8506万股，换手率0.06%，振幅1.42%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223734a221ba09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223734a221ba09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2503474586","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503474586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503474586?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 22:31","pubTimestamp":1736778708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下跌5.17%。截至发稿，该股报1.38美元/股，成交量7.8445万股，换手率0.04%，振幅1.38%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223148960252cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223148960252cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2502893471","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502893471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502893471?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 23:06","pubTimestamp":1736521614,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时06分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下跌5.43%。截至发稿，该股报1.22美元/股，成交量36.282万股，换手率0.21%，振幅3.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230655aba60bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230655aba60bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2501899097","title":"Tevogen Bio Holdings Inc.盤中異動 大幅跳水6.58%報1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501899097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501899097?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 22:36","pubTimestamp":1736260591,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时36分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水6.58%。截至发稿，该股报1.26美元/股，成交量23.6037万股，换手率0.13%，振幅3.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223632aba1e05f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223632aba1e05f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2495145386","title":"Tevogen Bio Holdings Inc.盤中異動 大幅跳水5.71%報0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495145386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495145386?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 23:08","pubTimestamp":1735657718,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时08分，Tevogen Bio Holdings Inc.股票出现波动，股价急速跳水5.71%。截至发稿，该股报0.990美元/股，成交量50.3321万股，换手率0.29%，振幅8.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231230838ab998972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231230838ab998972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2494437862","title":"Tevogen Bio Holdings Inc.盤中異動 早盤快速下挫5.14%報1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494437862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494437862?lang=zh_tw&edition=fundamental","pubTime":"2024-12-26 23:47","pubTimestamp":1735228071,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时47分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报1.02美元/股，成交量88.6674万股，换手率0.51%，振幅8.41%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226234751a20aa5cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226234751a20aa5cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2493799050","title":"Tevogen Bio Holdings Inc.盤中異動 下午盤股價大漲5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493799050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493799050?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 02:32","pubTimestamp":1734978720,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日02时32分，Tevogen Bio Holdings Inc.股票出现异动，股价急速上涨5.92%。截至发稿，该股报1.055美元/股，成交量61.9275万股，换手率0.35%，振幅7.93%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224023201984d3e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224023201984d3e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2492918793","title":"Tevogen Bio Holdings Inc.盤中異動 急速下跌5.88%報0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918793?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 05:01","pubTimestamp":1734469274,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日05时01分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.88%。截至发稿，该股报0.960美元/股，成交量116.481万股，换手率0.67%，振幅6.86%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218050114984c94b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218050114984c94b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2490286286","title":"Tevogen Bio Holdings Inc.盤中異動 大幅拉昇5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490286286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490286286?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 00:05","pubTimestamp":1733933143,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时05分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.06%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000543ab6ff947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000543ab6ff947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2490043805","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.14%報1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490043805?lang=zh_tw&edition=fundamental","pubTime":"2024-12-10 23:12","pubTimestamp":1733843567,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时12分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下挫5.14%。截至发稿，该股报1.02美元/股，成交量19.1463万股，换手率0.11%，振幅4.49%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.49%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231247984b0e2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210231247984b0e2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2489450908","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.31%報1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489450908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489450908?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 22:59","pubTimestamp":1733410740,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时59分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下跌5.31%。截至发稿，该股报1.07美元/股，成交量24.8334万股，换手率0.14%，振幅4.43%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225900a1d6a894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205225900a1d6a894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2488190436","title":"Tevogen Bio Holdings Inc.盤中異動 早盤快速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488190436?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 23:01","pubTimestamp":1733324466,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时01分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫5.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423010798e55e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423010798e55e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2488294612","title":"Tevogen Bio Holdings Inc.盤中異動 股價大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488294612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488294612?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 22:35","pubTimestamp":1733236513,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时35分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.85%。截至发稿，该股报1.11美元/股，成交量10.6683万股，换手率0.06%，振幅2.51%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223513a26997b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223513a26997b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2488677535","title":"Tevogen Bio Holdings Inc.盤中異動 大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488677535?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 22:39","pubTimestamp":1733150357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时39分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅跳水5.34%。截至发稿，该股报1.24美元/股，成交量19.3374万股，换手率0.11%，振幅3.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222391898e4ebbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222391898e4ebbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2487656115","title":"Tevogen Bio Holdings Inc.盤中異動 大幅下挫5.04%報1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487656115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487656115?lang=zh_tw&edition=fundamental","pubTime":"2024-11-30 00:16","pubTimestamp":1732896980,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时16分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报1.30美元/股，成交量78.2406万股，换手率0.45%，振幅6.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130001620971aab0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130001620971aab0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2486001268","title":"Tevogen Bio Holdings Inc.盤中異動 股價大漲7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486001268?lang=zh_tw&edition=fundamental","pubTime":"2024-11-26 22:46","pubTimestamp":1732632392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时46分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅拉升7.04%。截至发稿，该股报1.52美元/股，成交量48.5655万股，换手率0.28%，振幅8.39%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622463398e44ad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622463398e44ad8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2486425038","title":"Tevogen Bio Holdings Inc.盤中異動 快速下挫5.33%報1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486425038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486425038?lang=zh_tw&edition=fundamental","pubTime":"2024-11-25 22:35","pubTimestamp":1732545321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌5.33%。截至发稿，该股报1.42美元/股，成交量33.5565万股，换手率0.19%，振幅4.73%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223521abddfc26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223521abddfc26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2485303269","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485303269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485303269?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 22:30","pubTimestamp":1732285851,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时30分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫7.01%。截至发稿，该股报1.53美元/股，成交量16.9181万股，换手率0.10%，振幅1.52%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2484954110","title":"Tevogen Bio Holdings Inc.股價上漲21.76% 市值漲6149.18萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484954110?lang=zh_tw&edition=fundamental","pubTime":"2024-11-20 22:31","pubTimestamp":1732113077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升21.76%。截至发稿，该股报1.66美元/股，成交量1016.98万股，换手率5.96%，振幅1.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2484679388","title":"Tevogen Bio Holdings Inc.盤中異動 早盤股價大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484679388?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 22:41","pubTimestamp":1731940870,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时41分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.21%。截至发稿，该股报1.38美元/股，成交量16.9023万股，换手率0.10%，振幅4.11%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{}}}